| Autor: |
Buompadre MC; Servicio de Neurología Infantil, Hospital de Pediatría Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina. E-mail: mariabuompadre@gmail.com., González Rabelino G; Cátedra de Neuropediatría, Centro Hospitalario Pereira Rossell, Facultad de Medicina, UDELAR, Montevideo, Uruguay. |
| Jazyk: |
Spanish; Castilian |
| Zdroj: |
Medicina [Medicina (B Aires)] 2023 Sep; Vol. 83 Suppl 4, pp. 89-94. |
| Abstrakt: |
Despite advances in the identification and recognition of risk factors for pediatric arterial ischemic stroke, little progress has been made in hyperacute treatment. The most frequent risk factors are arteriopathies, cardiopathies, and thrombophilia. Early confirmation with neuroradiological studies is key to consider reperfusion therapies, which have limited evidence in pediatrics but a good safety profile. There is consensus on the use of anticoagulation in cardio-embolic and prothrombotic diseases, and antiplatelet therapy in arteriopathies. The future challenge is to improve coordination between prehospital services and specialized stroke centers to improve therapeutic management in the hyperacute stage and reduce morbidity and mortality. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
